Pricing and Reimbursement Model (PaR®)
DCI’s PaR Model was developed to help multidisciplinary teams develop the most effective clinical development program and other services to support optimal price and reimbursement for new products.  PaR was built using over two dozen analog cases to support the logic within it and allows the user to compare different development scenarios for the same product as well as compare different products.

Customer Impact Simulator™ (CIS)™
DCI’s CIS Model was developed to aid marketing professionals in pharmaceutical and biotechnology companies optimally plan resources across products and therapeutic areas.  CIS takes into account the total financial resources that are available, the effectiveness of different market actions and the needs of the key external stakeholders who will drive the product’s success.  

Forecasting Models
As a result of DCI’s industry experience and data analytic skills, it has developed a number of disease and financial forecast models both for pharmaceutical and biotechnology products and for healthcare services.  These models can be used individually or combined in a platform.